Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00571766Phase 3Completed
Phase 3, randomised, double-blind trial of arginine in hypertension (HTN), sponsored by University of Modena and Reggio Emilia. Primary endpoint: Blood pressure changes at 14 weeks. Started Nov 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00571766.